Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Design Therapeutics, Inc.
(Exact name of Registrant as Specified in its Charter)
|
|
|
|
|
|
|
|
|
|
|
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Share(2) |
Maximum Aggregate Offering Price(2) |
Fee Rate |
Amount of Registration Fee |
1 |
Equity |
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2021 Equity Incentive Plan |
Other |
3,019,902 |
$10.175 |
$30,727,502.85 |
0.00013810 |
$4,243.47 |
2 |
Equity |
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2021 Employee Stock Purchase Plan |
Other |
603,980 |
$8.649 |
$5,223,823.02 |
0.00013810 |
$721.41 |
|
Total Offering Amounts |
-- |
$35,951,325.87 |
-- |
$4,964.88 |
|
Total Fee Offsets |
-- |
-- |
-- |
-- |
|
Net Fee Due |
-- |
-- |
-- |
$4,964.88 |
|
|
|
Offering Note |
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Common Stock, $0.0001 par value per share (“Common Stock”) of Design Therapeutics, Inc. (the “Registrant”) that become issuable under the Registrant’s 2021 Equity Incentive Plan (the “2021 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction. The amount registered represents 3,019,902 shares of Common Stock that were automatically added to the shares authorized for issuance under the 2021 Plan on January 1, 2026 pursuant to an “evergreen” provision contained in the 2021 Plan. Pursuant to such provision, on January 1st of each year commencing in 2022 and ending on (and including) January 1, 2031, the number of shares authorized for issuance under the 2021 Plan is automatically increased by a number equal to: (a) 5% of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; or (b) a lesser number of shares of Common Stock as the Registrant’s board of directors (the “Board”) may designate no later than December 31st of the immediately preceding year. The proposed maximum offering price per unit and maximum aggregate offering price are estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) of the Securities Act using the average of the high and low prices of the Registrant’s Common Stock on March 2, 2026, as reported by The Nasdaq Global Select Market. |